Siobhan McKenna-Power has over 20 years of experience designing and delivering regulated systems, with over 8 years designing and delivering RTSM systems for clinical trials. She first developed an interest in clinical trials when her father took part in multiple Phase III drug and device trials due to his progressive Chronic Obstructive Pulmonary Disease and was eager to contribute in her own way when the opportunity presented herself.
Siobhan is a strong believer in first time quality and works with our sponsors to understand complex protocols. Siobhan has a keen understanding of what the needs of the end user are and works to ensure that even the most complex trials are easy for Investigators to work with, and that patient safety is the foremost priority of any RTSM system.
Siobhan is a graduate of Maynooth University (formerly National University of Ireland, Maynooth) with a BSc in Computer Science and Software Engineering. She is currently working on a Level 7 Diploma in Risk Management.
Giulia Rancati worked across biotech, academia and government organisations in the USA, Europe and South-East Asia. In 2021, she then transitioned to F. Hoffmann – La Roche where she leads the R&D Market Solutions Lead in Insights and Solutions. Here, Giulia is coaching a global team that focuses on co-creating and delivering R&D solutions to increase preclinical and clinical efficiency.
Dr. Francesca Maraschin serves as a Clinical Associate at Huma, where she plays a pivotal role in evidence generation across Huma’s products. Her professional background encompasses working as a clinician in pediatrics, pediatric surgery, and intensive care in South Africa, equipping her with a comprehensive understanding of healthcare challenges and solutions.
Francesca earned a Masters in International Health with distinction from the University of Oxford. Post-graduation, she expanded her scope by joining Oxford’s Nuffield Department of Medicine as a researcher, spearheading global health research exploring the care needs of neonates post-surgery.
Francesca is passionate about improving access to healthcare through digital health and by harnessing her clinical and research expertise is actively contributing to Huma’s transformative mission
Dr. Bernhard Remes serves as a Managing Director for Alcedis – a Huma company. After his Master’s degree in biology, completed in 2011, Bernhard started a PhD in micro and molecular biology, successfully completing it in 2015 in the field of “small RNA interaction in bacteria”. After a year as a Postdoc, he joined Alcedis in 2016 as a business analyst for EDC systems. In 2017, he moved to data management and the following year took over the data management department as functional unit manager. In 2020, Bernhard received Prokura and since summer 2021, he is part of the executive management team at Alcedis, where he is now in charge of Clinical Operations (Project Management, Monitoring, Medical Writing, Regulatory Affairs) and Data Operations (Data Management, Pharmacovigilance, Statistics).
Head of Clinical Study Management Team with over 15-years of experience within the clinical research industry.
Extensive scientific experience in planning of pre-clinical-, bioequivalence-, phase III and IV – studies design. Experienced project leader in preclinical and clinical studies execution. Supervisor of GCP compliant system, author of SOPs and auditor of vendors.
Leading a group of clinical specialist responsible for studies execution according to EMA/TPF/FDA regulations and GCP/GMP requirements.
With over 20 years’ experience in clinical research – my career started within NHS UK Study Project Management diversifying into a range of operational and strategic focused positions. Currently leading European Head Quarters Operations Teams across Europe/International region.
I have had the pleasure of working through all phases in major pharmaceutical companies. I pride myself in being a motivational leader with strong vision on teamwork, delivery and respect, focusing on scientific delivery to patients. I have operationally led GCP inspections, also additional country/site inspections with a strong focus on quality excellence and oversight. I have a passion for collaborating with all sites globally, partnering and bringing the best relationships forward for investigators, their teams and our patients.
Improving Clinical Drug Development. Physician specialized in Clinical Pharmacology. Long standing experience in clinical drug development
